The standard of care for locally advanced cervical cancer is external beam radiation (EBRT) and chemotherapy followed by a brachytherapy boost. Despite the body of evidence supporting the survival benefit of brachytherapy, studies have shown a decreased use of brachytherapy over time as well as low baseline brachytherapy use overall. This study hopes to better characterize the utilization of brachytherapy for cervical cancer in Oregon and identify disparities in delivery of care.